logo
Menu

Non Residents Abstracts

MEIDAM DUBAI

Abstract Submissions Are Closed.

Acceptance of Non-Residents Abstracts (STD)

MEIDAM Congress Dubai 2026 Abstract Submission Guideline
(Both Oral & Poster type)

The 11th International Congress of Medical Excellence in Dermatology & Aesthetic Medicine provides the perfect opportunity for you to showcase your research and advancements in the field to industry professionals.

Click to Submit Non-Residents Abstracts (STD)
  1. All MEIDAM Association Members & Non-Members are welcome to submit your abstracts in any area related to the combined specialty of Dermatology and Aesthetic Medicine. Original research studies will be preferable for Oral Abstracts.
  2. Any Residents abstracts received under this category will be rejected for Scientific Committee Review. Use theright submission link.
  3. The presenters applying under this category should either be Medical Students, Board Certified dermatologist or a Post Graduation degree equivalent etc.(Only Medical Students/Researchers/Scientists/Physicians)
  1. Presenters may submit their Abstracts of their latest research on the following topics:
    1. Clinical Dermatology & Skin Disease
      • Emerging Advances in Clinical Dermatology
      • Inflammatory, STDs and Infectious Skin Diseases
      • Autoimmune, Bullous and blistering Skin Disorders
      • Pediatric Dermatology
      • Dermatologic Surgery and Procedural Dermatology
      • Challenging Dermatology Cases
    2. Pigmentary Disorders & Photodermatology
      • Melasma and Hyperpigmentation
      • Vitiligo and Hypopigmentation Disorders
      • Advances in Photodermatology
      • Skin Quality and Barrier Function
    3. Hair, Nail & Scalp Disorders
      • Alopecia and Hair Disorders
      • Scalp Diseases and Trichology
      • Nail Disorders
      • Emerging Hair Regeneration Therapies
    4. Aesthetic Dermatology & Injectables
      • Neuromodulators and Dermal Fillers
      • Injectable Complications and Safety
      • Biostimulators and Regenerative Injectables
      • Skin Boosters, Polynucleotides and Exosomes
      • Male Aesthetics
      • Aesthetic Treatments in Skin of Color
      • Cosmeceuticals in Dermatology Practice
    5. Lasers & Energy-Based Devices
      • Laser Dermatology
      • Energy-Based Devices for Skin Rejuvenation
      • Device-Based Body Contouring
      • Laser Applications in Plastic Surgery
      • Energy-Based Devices in Aesthetic Gynecology
    6. Regenerative Medicine, Longevity & Advanced Therapeutics
      • Regenerative Medicine in Dermatology
      • Skin Aging Biology and Biomarkers
      • Longevity and Preventive Dermatology
      • NAD+ and Skin Aging
      • Peptides in aesthetic dermatology
      • Ethosomes and Advanced Drug Delivery Systems
      • Gut–Skin Axis and Dermatologic Aging
      • Nutrition, Lifestyle and Skin Health
    7. Digital Dermatology, AI & Practice Evolution
      • Artificial Intelligence in Dermatology
      • Digital Dermatology and Imaging Technologies
      • Ethical Social Media Use in Dermatology Practice
      • Regulatory Compliance in Dermatology Practice
      • Practice Management in Aesthetic Medicine
      • Collaboration with Aesthetic Therapists

    Additional Abstract Types Accepted

    • Clinical Case Reports
    • Innovative Techniques
    • Clinical Trials and Research Studies
    1. Presenters may submit their recent research observations in clinical studies, recent advances, their impact on dermatology practice, innovations & future directions.
    2. POSTER PRESENTERS can present new ideas and original observations of scientific information for any of the above listed topics utilizing narrative material, photographs, charts, diagrams, etc.
  1. Original research and Case Series / Reports about Dermatology & Aesthetic Medicine will be prioritized for acceptance.
  2. Abstract Authors may provide consent (approved by all co- authors) for their Accepted Abstract to be filed/recorded by the conference to be made available for use in dissemination as educational content on any MEIDAM association platform deemed necessary by the committee and Board members.
  3. The abstract text body is limited 500 words including spaces.
  4. Enter the Title using ‘Sentence case’ and should be brief and self-explanatory. The title should be as brief as possible but long enough to clearly indicate the nature of the study.
  5. Original research Abstract Submissions should include the following:
  • Background
  • Aims & Objectives
    Clearly state the purpose of the abstract.
  • Methods
    Describe your selection of observations or experimental subjects clearly.
  • Results
    Present your results in a logical sequence in text, table and illustrations.
  • Conclusions
    Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
  1. Case reports and Case series should include the below structure:
    • Introduction
    • Case report/series
    • Discussion
  1. All abbreviations must be defined in first use. Abstracts are required for all presentations.
  2. No identifying features such as names of authors, hospitals, medical schools, clinics, or cities may be listed with the TITLE or abstract text, as a “blind” review process will be used as per any Journal publication guidelines if applicable. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online whilst completing the Abstract FORM.
  3. Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
  4. Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. Scientific committee reserves the right to replace any brand name with a generic name without further notice.
  5. Images that are uploaded to follow the abstract are not guaranteed inclusion in the congress materials.
  1. There are no limitations on the number of abstracts an individual can submit, however a maximum of 2 abstracts, either in Oral & a Poster category, shall be accepted.

You are invited to submit an abstract for the 11th International Congress Edition of the Medical Excellence in Dermatology and Aesthetic Medicine, to be held on 24 – 26 September 2026, at the Dubai World Trade Centre , Sheikh Rashid Hall, Dubai, United Arab Emirates.

SUBMISSION & CONFIRMATION TIMELINES

  • Abstract submission opens on 10th March 2026, Tuesday
  • Final Call 20th April 2026, Monday
  • Deadline for Submission : 
    • ORAL Abstracts: 30th April 2026, Thursday
    • Poster Abstracts : 30 June 2026, Tuesday
  • Notification of acceptance / Rejection 
    • ORAL Abstracts: 1st June 2026, Thursday
    • Poster Abstracts : 30 July 2026, Tuesday